SCHEMBL17596509

SCHEMBL17596509

COC(=O)c1cc(Br)c(N)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.50
ALDH1A1 P00352 6/20 0.50
GAA P10253 5/20 0.50
HSD17B10 Q99714 3/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 2/20 0.50
GLA P06280 2/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
ATM Q13315 1/20 0.50
CFTR P13569 3/20 0.46
ABL1 P00519 1/20 0.45
TSHR P16473 2/20 0.44
ALOX15 P16050 1/20 0.44
SOS1 Q07889 1/20 0.41
CYP1A2 P05177 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41
DRD1 P21728 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8473587 0.93 KDM4E (0.50) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL274700 0.87 KDM4E (0.55) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL17792409 0.86 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10HPGD
Hydrochloric Acid SCHEMBL5417457 0.85 KDM4E (0.53) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL1720999 0.85 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL30107294 0.83 NOTUM (0.45) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL2318882 0.83 KDM4E (0.55) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL30280995 0.83 KDM4E (0.55) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL155216 0.83 NOTUM (0.45) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL20036871 0.83 KMT2A (0.44) KDM4EALDH1A1GAAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119859155-A Tri-fused ring derivative inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2025-04-22 CN disclosed
CN-106715425-B Herbicidal quinolines 先正达参股股份有限公司 2020-11-06 CN disclosed
EP-3191465-B1 HERBICIDAL QUINOLINES SYNGENTA PARTICIPATIONS AG (CH) 2018-12-19 EP disclosed
US-9980486-B2 Herbicidal quinolines SYNGENTA PARTICIPATIONS AG (CH) 2018-05-29 US disclosed
US-20170251670-A1 HERBICIDAL QUINOLINES SYNGENTA PARTICIPATIONS AG (CH) 2017-09-07 US disclosed
EP-3191465-A1 HERBICIDAL QUINOLINES Syngenta Participations AG (CH) 2017-07-19 EP disclosed
WO-2016038173-A1 HERBICIDAL QUINOLINES SYNGENTA PARTICIPATIONS AG (CH) 2016-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170251670-A1 HERBICIDAL QUINOLINES NQO2, DDT, ATP1B1 KDM4E 1955/4885ALDH1A1 33/4885GAA 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.